|
ARCA Biopharma: An Undervalued Biotech With A Bright Future (ABIO)
Seeking Alpha On February 3, 2014, ARCA filed an 8-K with the SEC disclosing a public offering for 5,116,228 shares of common stock and warrants to purchase an aggregate of 1,279,057 shares of common stock at a purchase price of $1.70 per share. Net proceeds were … |
